Company / SG&A Expense
Dentsply Sirona SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$1.4B
FY2025
5-year range
$1.4B / $1.6B
FY2021-FY2025
Trend
-10.4%
vs FY2024
Sector context
#35 of 152
Health Care
What the data says
Dentsply Sirona's sg&a expense of $1.4B is higher than 77% of companies in the Health Care sector (FY2025). SG&A Expense has fluctuated over the past 10 years, ranging from $1.3B in FY2020 to $1.7B in FY2018.
Based on SEC 10-K filings.
$1.4B in FY2025 with a 5-year CAGR of +2.0%. Top quartile in the Health Care sector.
Improved from $1.6B to $1.4B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -3.3%
- 5-Year CAGR
- +2.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 152This company $1.4B Sector average $182.7B
▼
-99.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.0%, indicating consistent growth.
- In FY2025, sg&a expense decreased 10.4% year-over-year.
- Ranks #35 out of 152 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.42 (distress zone, below 1.8 threshold)
- Negative profit margin: -24.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4B | -10.4% |
| FY2024 | $1.6B | -0.5% |
| FY2023 | $1.6B | +1.5% |
| FY2022 | $1.6B | +2.5% |
| FY2021 | $1.6B | +19.1% |
| FY2020 | $1.3B | -17.6% |
| FY2019 | $1.6B | -8.1% |
| FY2018 | $1.7B | +2.6% |
| FY2017 | $1.7B | +10.0% |
| FY2016 | $1.5B | +41.4% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026